On Wednesday SOHM Inc (OTCMKTS:SHMN) was in sharp focus among investors after a significant development and the stock surged by as much as 20% after investors piled on to it in a big way. The company is nutraceutical, generic pharmaceutical and cosmeceutical.
Yesterday, it emerged that SOHM had been given the mandate for the supply, manufacturing and development of a pair of products that are meant for the purposes of human tropical prescription applications. The mandate for the same was received by the Chief Executive Officer of the company Baron Night. It goes without saying that it is a significant new opportunity for the company and the rally in the SOHM stock did not come as a surprise.
One of the products is meant for lightening some of the dark patches on the human skin that are brought about by hormone medicines, pregnancy and injuries to the skin among other reasons.
The other product that the company has got a mandate for is a combined medication that is meant for treating swelling, itching and discomfort that are caused by haemorrhoids as well as other anal problems. At this point, it might be a good move for investors to keep the SOHM stock in their watch lists.